LIR-6/LILRA1 Antibody (586439) [DyLight 488]

• Reactivity: Hu
• Applications: ICC/IF
• Clone: 586439
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: DyLight 488

LIR-6/LILRA1 Antibody (586439) [DyLight 488] Summary

• Immunogen: Mouse myeloma cell line, NS0-derived human LILRA1/CD85i/LIR-6
  Pro17-Asn461
  Accession # O75019
• Specificity: Detects human LILRA1/CD85i/LIR-6 in direct ELISAs. In direct ELISAs, no cross-reactivity with human LILRA2, LILRA3, LILRA4, LILRA5, LILRA6, LILRB2 and LILRB3 was observed.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • Immunocytochemistry
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein A or G purified from hybridoma culture supernatant

Notes

DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

Alternate Names for LIR-6/LILRA1 Antibody (586439) [DyLight 488]

• CD85 antigen-like family member I
• CD85i antigen
• CD85i
• leukocyte immunoglobulin-like receptor subfamily A member 1 soluble isoform
• leukocyte immunoglobulin-like receptor subfamily A member 1
• leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1
• LILRA1
• LIR6
• LIR-6
• LIR-6Leukocyte immunoglobulin-like receptor 6
• LIR6MGC126563

Background

LILRA3 is a member of leukocyte immunoglobulin-like receptor gene family. Leukocyte Ig-like receptors (LIRs) are a family of inhibitory and stimulatory immunoreceptors expressed predominantly on monocytes and B cells and at lower levels on dendritic cells and natural killer (NK) cells. LILRA3 lacks a transmembrane region and may act as a soluble receptor for class I MHC antigens. It is expressed in B-cells, and at lower levels in natural killer (NK) cells.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.